Single - cell Sequencing in Stem Cell Nanotargeted Therapy for Triple - negative Breast Cancer
DOI:
https://doi.org/10.61173/qhpwna65Keywords:
Triple-negative breast cancer, Single-cell RNA sequencing, Nanotargeted therapy, Immune microenvironment, Cancer Stem CellsAbstract
Triple-negative breast cancer (TNBC) lacks the expression of three Targeted hormone receptors, namely Estrogen receptor (ER), Progesterone receptor (PR), and Human epidermal growth factor receptor 2 (HER2), leading to difficulties in implementing Targeted therapy. Its high Heterogeneity is primarily regulated by the Interaction between the Tumor microenvironment (TME) and Cancer stem cell subpopulations (CSCs). The Immunosuppressive microenvironment within the TME promotes the survival and Metastasis of tumor stem cells, while CSCs, by secreting Immune checkpoint molecules, in turn promote the immunosuppressive microenvironment and simultaneously remodel the TME.This study, by investigating their interactions and the integration of single-cell RNA sequencing (sc-RNAseq) technology, aims to identify the Heterogeneity of Triple-negative breast cancer stem cells (TNBC-CSCs) and their surface markers, to elucidate the molecular characteristics, regulatory mechanisms, and functional properties of CSCs, and to seek prognosis-related therapeutic targets for different subtypes of TNBC. Simultaneously, novel nanomaterials, such as nCOF, will be utilized to deliver drugs to overcome the difficulties in drug delivery for TNBC, thereby achieving precise drug release.
References
[1] Szulc, A. & Wozniak, M. Targeting Pivotal Hallmarks of [14] Zolota, V. et al. Epigenetic Alterations in Triple-Negative Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer-The Critical Role of Extracellular Matrix. Cancers Breast Cancer Treatment-In Vitro, In Vivo and Clinical Trials 13, doi:10.3390/cancers13040713 (2021). Literature Review. Cancers 16, doi:10.3390/cancers16081483 [15] Rastogi, S. et al. NF-κB mediated regulation of tumor (2024). cell proliferation in hypoxic microenvironment. Frontiers in
[2] Tzec-Interián, J. A., González-Padilla, D. & Góngora- Pharmacology 14, doi:10.3389/fphar.2023.1108915 (2023). Castillo, E. B. Bioinformatics perspectives on transcriptomics: A [16] Kuchnio, A. et al. The Cancer Cell Oxygen Sensor PHD2 comprehensive review of bulk and single-cell RNA sequencing Promotes Metastasis via Activation of Cancer-Associated analyses. Quantitative Biology 13, doi:10.1002/qub2.78 (2025). Fibroblasts. Cell Reports 12, 992-1005, doi:10.1016/
[3] Li, M., Yan, T. T., Wang, M. Z., Cai, Y. Q. & Wei, Y. j.celrep.2015.07.010 (2015). Y. Advances in Single-Cell Sequencing Technology and Its [17] Werno, C. et al. Knockout of HIF-1α in tumor-associated Applications in Triple-Negative Breast Cancer. Breast Cancer- macrophages enhances M2 polarization and attenuates their Targets and Therapy 14, 465-474, doi:10.2147/bctt.S388534 pro-angiogenic responses. Carcinogenesis 31, 1863-1872, (2022). doi:10.1093/carcin/bgq088 (2010). Dean&Francis ISSN 2959-409X
[18] Goetze, K., Walenta, S., Ksiazkiewicz, M., Kunz- framework as a drug delivery vehicle towards triple negative Schughart, L. A. & Mueller-Klieser, W. Lactate enhances breast cancer malignancy. Nanoscale Advances 4, 2313-2320, motility of tumor cells and inhibits monocyte migration doi:10.1039/d2na00103a (2022). and cytokine release. Int J Oncol 39, 453-463, doi:10.3892/ [24] Li, Y. et al. Nanosensitizer-mediated augmentation of ijo.2011.1055 (2011). sonodynamic therapy efficacy and antitumor immunity. Nature
[19] Xia, L. et al. The cancer metabolic reprogramming and Communications 14, 6973, doi:10.1038/s41467-023-42509-7 immune response. Molecular Cancer 20, 28, doi:10.1186/ (2023). s12943-021-01316-8 (2021). [25] Mitra, S. et al. Targeted Drug Delivery in Covalent Organic
[20] Longhitano, L. et al. The Crosstalk between GPR81/ Nanosheets (CONs) via Sequential Postsynthetic Modification. IGFBP6 Promotes Breast Cancer Progression by Modulating Journal of the American Chemical Society 139, 4513-4520, Lactate Metabolism and Oxidative Stress. Antioxidants 11, 275 doi:10.1021/jacs.7b00925 (2017). (2022). [26] Ren, X. W., Kang, B. X. & Zhang, Z. M. Understanding
[21] David, N. et al. Tumor-associated Tregs obstruct antitumor tumor ecosystems by single-cell sequencing: promises and immunity by promoting T cell dysfunction and restricting limitations. Genome Biology 19, doi:10.1186/s13059-018- clonal diversity in tumor-infiltrating CD8+ T cells. Journal for 1593-z (2018). ImmunoTherapy of Cancer 10, e004605, doi:10.1136/jitc-2022- [27] Liu, J., Su, R., Zhang, J. & Wei, L. Classification and gene 004605 (2022). selection of triple-negative breast cancer subtype embedding
[22] Yu, Y. et al. Designed fabrication of active tumor targeting gene connectivity matrix in deep neural network. Briefings in covalent organic framework nanotherapeutics via a simple post- Bioinformatics 22, doi:10.1093/bib/bbaa395 (2021). synthetic strategy. Nano Research 16, 7085-7094, doi:10.1007/ [28] Chen, Z. et al. A Machine Learning Model to Predict the s12274-022-5265-7 (2023). Triple Negative Breast Cancer Immune Subtype. Frontiers in
[23] Das, S. K. et al. A conjugated 2D covalent organic Immunology Volume 12 - 2021 (2021).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
